$173.96
2.1%
Price vs. AI Score (Last 150 days)
Data gathered: December 6
Data gathered: December 6
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 48 2.1% |
|
| Sentiment | 92 0% |
|
| Webpage traffic | 37,000 -20.2% |
|
| Employee Rating | 72 0% |
|
| Google Trends | 22 0% |
|
| Linkedin Employees | 2,281 N/A |
|
| Patents | 338 0% |
|
| 4chan Mentions | 0% | N/A |
| Facebook Engagement | 226 49.7% |
|
| Facebook followers | 135 0.7% |
|
| Stocktwits Mentions | 1 0% |
|
| Stocktwits Subscribers | 3,965 0% |
|
| Twitter Followers | 16,316 -0% | N/A |
| Youtube Subscribers | 2,060 0% |
|
| Instagram Followers | 1,277 0.1% |
|
| News Mentions | 1 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 71 0% |
|
In the news
 |
Pro Research: uncovering the potential of Wall Street's biotech starDecember 4 - Investing.com |
U.S. strong buy ideas for the next 12 months – according to CitiDecember 3 - Seeking Alpha |
|
Biotechs post record gains in November amid improving outlookDecember 2 - Seeking Alpha |
|
 |
Arrowhead Pharmaceuticals: Balance Sheet Concern Needs To Be AddressedNovember 30 - SeekingAlpha |
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2023November 29 - Yahoo |
|
 |
Alnylam Pharmaceuticals tops list of largest companies for the third yearNovember 29 - The Boston Globe |
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.
| Price | $173.96 |
| Target Price | Sign up |
| Market Cap | $21.5B |
| Dividend Yield | 0.0252 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 720M | 279M | 441M | 148M | 182M |
| Q2 '23 | 289M | 290M | -1.3M | -276M | -244M |
| Q1 '23 | 290M | 225M | 65M | -174M | -143M |
| Q4 '22 | 335M | 257M | 79M | -207M | -177M |
| Q3 '22 | 264M | 272M | -8.1M | -406M | -235M |
Insider Transactions
| Garg Pushkal filed to sell 4,345 shares at $185.3. August 7 '23 |
| Vaishnaw Akshay filed to sell 22,774 shares at $189.3. August 7 '23 |
| Greenstreet Yvonne filed to sell 35,216 shares at $189.3. August 7 '23 |
| Poulton Jeffrey V. filed to sell 15,873 shares at $189.3. August 7 '23 |
| BONNEY MICHAEL W filed to sell 16,029 shares at $187.7. August 4 '23 |
Read more about Alnylam Pharmaceuticals and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, business outlook.